Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03237156
What this trial is testing

Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants

Who this might be right for
Japanese Healthy Adult Male Participants
Takeda 24
Early research (Phase 1)Study completedNCT05686980
What this trial is testing

Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants

Who this might be right for
Healthy Volunteers
AbbVie 18
Early research (Phase 1)Study completedNCT03083561
What this trial is testing

LY3337641 in Japanese and Caucasian Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 36
Early research (Phase 1)Looking for participantsNCT07745907
What this trial is testing

Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

Who this might be right for
Healthy Participants
Amgen 28
Early research (Phase 1)Study completedNCT02902978
What this trial is testing

A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

Who this might be right for
Japanese Healthy Adult Male Participants
EA Pharma Co., Ltd. 56
Early research (Phase 1)Ended earlyNCT06144697
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 267
Early research (Phase 1)Ended earlyNCT02188303
What this trial is testing

LY2944876 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
Healthy Volunteers
OPKO Health, Inc. 48
Early research (Phase 1)Study completedNCT05068466
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of INCB054707

Who this might be right for
Healthy Participants
Incyte Biosciences Japan GK 30
Early research (Phase 1)Study completedNCT04981431
What this trial is testing

Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Bayer 62
Early research (Phase 1)Active Not RecruitingNCT07693231
What this trial is testing

Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight

Who this might be right for
HealthyObesity
Boehringer Ingelheim 48
Early research (Phase 1)Study completedNCT04896541
What this trial is testing

Phase I Double-blind, Placebo-controlled Study of AZD7442

Who this might be right for
COVID-19
AstraZeneca 40
Early research (Phase 1)Study completedNCT03042299
What this trial is testing

A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation

Who this might be right for
Japanese Healthy Adult Male Participants
Takeda 14
Early research (Phase 1)Study completedNCT01879722
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

Who this might be right for
Schizophrenia
Takeda 77
Early research (Phase 1)Study completedNCT02752919
What this trial is testing

Study of Galunisertib in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 40
Early research (Phase 1)Study completedNCT02018536
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Who this might be right for
Healthy
Janssen R&D Ireland 48
Early research (Phase 1)Study completedNCT06519968
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.

Who this might be right for
Healthy Participants
AstraZeneca 56
Early research (Phase 1)Study completedNCT07221084
What this trial is testing

Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy Volunteers
Crinetics Pharmaceuticals Inc. 21
Early research (Phase 1)Study completedNCT01631487
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 86
Early research (Phase 1)Study completedNCT05107336
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 44
Early research (Phase 1)Study completedNCT05003440
What this trial is testing

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Who this might be right for
Healthy VolunteersAtherosclerotic Cardiovascular Disease
Novo Nordisk A/S 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation